These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2861276

  • 1. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E, Bohmaker K, Goldstein M, Friedhoff AJ.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [Abstract] [Full Text] [Related]

  • 2. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX, Hatada Y, Black LE, Creese I, Sibley DR.
    J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
    [Abstract] [Full Text] [Related]

  • 3. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY, Martin-Iverson MT.
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [Abstract] [Full Text] [Related]

  • 4. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD, Duffy RA, Coffin VL, Chipkin RE, Barnett A.
    J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
    [Abstract] [Full Text] [Related]

  • 5. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D, Di Paolo T.
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [Abstract] [Full Text] [Related]

  • 6. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M, Lévesque D, Di Paolo T.
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR.
    Eur J Pharmacol; 1992 Jan 21; 210(3):279-84. PubMed ID: 1351844
    [Abstract] [Full Text] [Related]

  • 8. Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.
    Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I.
    J Pharmacol Exp Ther; 1993 May 21; 265(2):498-508. PubMed ID: 7684443
    [Abstract] [Full Text] [Related]

  • 9. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Neuropharmacology; 1994 May 21; 33(5):647-55. PubMed ID: 7936100
    [Abstract] [Full Text] [Related]

  • 10. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 11. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K, Meller E, Goldstein M, Benfenati F, Agnati LF.
    Neurosci Lett; 1986 Feb 28; 64(2):163-8. PubMed ID: 3960398
    [Abstract] [Full Text] [Related]

  • 12. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F, Hervé D, Blanc G, Glowinski J, Tassin JP.
    J Neurochem; 1992 Jul 28; 59(1):331-7. PubMed ID: 1351927
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors.
    Hess EJ, Norman AB, Creese I.
    J Neurosci; 1988 Jul 28; 8(7):2361-70. PubMed ID: 2907912
    [Abstract] [Full Text] [Related]

  • 14. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ, Battaglia G, Norman AB, Creese I.
    Mol Pharmacol; 1987 Jan 28; 31(1):50-7. PubMed ID: 3100940
    [Abstract] [Full Text] [Related]

  • 15. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 28; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P, Boyson SJ, Reuter S, Molinoff PB.
    Synapse; 1989 Sep 28; 3(1):74-82. PubMed ID: 2521960
    [Abstract] [Full Text] [Related]

  • 17. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A, Minneman KP.
    Mol Pharmacol; 1987 Nov 28; 32(5):655-62. PubMed ID: 2891027
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A.
    J Pharmacol Exp Ther; 1988 Dec 28; 247(3):1093-102. PubMed ID: 2905002
    [Abstract] [Full Text] [Related]

  • 19. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L, Zivin M, Sket D.
    J Pharmacol Exp Ther; 1999 Mar 28; 288(3):1093-100. PubMed ID: 10027846
    [Abstract] [Full Text] [Related]

  • 20. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL.
    J Pharmacol Exp Ther; 1993 Aug 28; 266(2):557-62. PubMed ID: 8102643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.